Dehydroepiandrosterone sulfate

[1]Baulieu EE, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci U S A. 2000 Apr 11;97 (8) :4279-84.|[2]Maninger N, et al. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) . Front Neuroendocrinol. 2009 Jan;30 (1) :65-91.|[3]Dillon JS. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr Drug Targets Inflamm Allergy. 2005 Jun;4 (3) :377-85.|[4]Barrett-Connor E, et al. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med. 1986 Dec 11;315 (24) :1519-24.|[5]Altman R, et al. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul Pharmacol. 2008 Feb-Mar;48 (2-3) :76-84.|[6]Sicard F, et al. Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc Natl Acad Sci U S A. 2007 Feb 6;104 (6) :2007-12.|[7]Tabuchi K, et al. Dehydroepiandrosterone sulfate reduces acoustic injury of the guinea-pig cochlea. J Pharmacol Sci. 2005 Oct;99 (2) :191-4.|[8]Maayan R, et al. The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression. Eur Neuropsychopharmacol. 2005 May;15 (3) :253-62.|[9]Reddy DS, et al. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol. 1998 Mar 12;345 (1) :55-9.

Eur J Pharmacol. 2024 Sep 12:176995.|Toxicol Appl Pharmacol. 2022 Apr 15:441:115969.|Cell Metab. 2024 Nov 5;36 (11) :2402-2418.e10.|Nat Chem Biol. 2022 Nov;18 (11) :1196-1203.|Research Square Print. 2022 May.